Clinical Trial

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

Name: A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients — clinical trial record (NCT07303660)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a clinical study aiming to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of ZE50-0134 in relapsed and refractory Acute Myeloid Leukemia patients.

Trial Details

NCT Number	NCT07303660
Lead Sponsor	Lomond Therapeutics Holdings, Inc.
Conditions	Acute Myeloid Leukemia
Enrollment	66 participants
Start Date	2026-01-10
Primary Completion	2026-09 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2025-12-26